The FDA-Approved Antiviral Raltegravir Inhibits Fascin1-Dependent Invasion of Colorectal Tumor Cells In Vitro and In Vivo.
Alburquerque-González B, Bernabé-García Á, Bernabé-García M, Ruiz-Sanz J, López-Calderón FF, Gonnelli L, Banci L, Peña-García J, Luque I, Nicolás FJ, Cayuela-Fuentes ML, Luchinat E, Pérez-Sánchez H, Montoro-García S, Conesa-Zamora P.
Alburquerque-González B, et al. Among authors: bernabe garcia a.
Cancers (Basel). 2021 Feb 18;13(4):861. doi: 10.3390/cancers13040861.
Cancers (Basel). 2021.
PMID: 33670655
Free PMC article.